Literature DB >> 6251504

Short-term hormonal effects of naloxone in man.

J Volavka, J Bauman, J Pevnick, D Reker, B James, D Cho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6251504     DOI： 10.1016/0306-4530(80)90026-8

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN： 0306-4530            Impact factor:   4.905


× No keyword cloud information.
  11 in total

1.  Gonadal steroids do not affect basal growth hormone response to naloxone in humans.

Authors:  P Monteleone; M Maj; M Iovino; L Fiorenza; P M Fiumani; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Measuring behavioral and endocrine responses to novelty stress in adult zebrafish.

Authors:  Jonathan Cachat; Adam Stewart; Leah Grossman; Siddharth Gaikwad; Ferdous Kadri; Kyung Min Chung; Nadine Wu; Keith Wong; Sudipta Roy; Christopher Suciu; Jason Goodspeed; Marco Elegante; Brett Bartels; Salem Elkhayat; David Tien; Julia Tan; Ashley Denmark; Thomas Gilder; Evan Kyzar; John Dileo; Kevin Frank; Katie Chang; Eli Utterback; Peter Hart; Allan V Kalueff
Journal:  Nat Protoc       Date:  2010-10-14       Impact factor: 13.491

3.  Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.

Authors:  Eliza B Geer; Rita E Landman; Sharon L Wardlaw; Irene M Conwell; Pamela U Freda
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone.

Authors:  Elizabeth Ducat; Brenda Ray; Gavin Bart; Yoshie Umemura; Jack Varon; Ann Ho; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2011-04-20       Impact factor: 4.280

5.  d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.

Authors:  D P van Kammen; S C Schulz
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

7.  Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.

Authors:  D Papalia; M Lunetta; M Di Mauro
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

8.  Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.

Authors:  F Petraglia; G Comitini; G D'Ambrogio; A Volpe; F Facchinetti; G Alessandrini; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

Review 9.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Authors:  Yan Zhou; Dmitri Proudnikov; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2009-11-12       Impact factor: 3.252

10.  Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.

Authors:  D Naber; D Pickar; G C Davis; R M Cohen; D C Jimerson; M A Elchisak; E G Defraites; N H Kalin; S C Risch; M S Buchsbaum
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.